Arslan, D. Et Al. 2021. Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience. MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL , 589-590.

Arslan, D., Acar-Ozen, N. P., Tuncer, A., & Karabudak, R., (2021). Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience. MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, 589-590.

Arslan, DORUK Et Al. "Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience," MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, 589-590, 2021

Arslan, DORUK Et Al. "Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience." MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, pp.589-590, 2021

Arslan, D. Et Al. (2021) . "Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience." MULTIPLE SCLEROSIS JOURNAL , vol.27, no.2_SUPPL, pp.589-590.

@article{article, author={DORUK ARSLAN Et Al. }, title={Evaluation of immunoglobulin levels and COVID-19 disease course in patients with multiple sclerosis under ocrelizumab therapy: a tertiary center experience}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2021, pages={589-590} }